World--class care without delay
As the UK’s leading private cancer specialist, we are dedicated to providing the latest evidence-based treatments from around the world, in a high quality, safe environment – because cancer is all we do.
At our new state-of-the-art centre at Cromwell Hospital in London, we have the world’s most advanced radiotherapy technologies – Gamma Knife Icon, Varian Edge and MRIdian MR linac*. Having these three machines under one roof will make our centre Europe’s most advanced radiotherapy facility.
The centre specialises in complex and difficult-to-treat tumours including cancers of the brain and spine, abdomen, head and neck, lung and oligometasatic cancer as well as breast and prostate cancer.
*Summer 2021. Patients can currently be treated at our MRIdian centre in Oxford
Enhancing the patient journey
Our goal is to deliver exceptional treatment and care in a way which enhances every aspect of the patient’s cancer journey. From diagnosis through to palliative care, all our patients receive the very best personalised care and a consultant-led treatment plan which also embraces life-changing approaches such as exercise medicine and wellbeing therapies.
Our centre works in partnership with Cromwell Hospital which has comprehensive diagnostic facilities. Our rapid access pathways ensure that patients can start treatment within days of a diagnosis if needed.
Patients can be referred to one of the surgeons or oncologists who work with us.
Our highly experienced cancer experts work as teams to ensure that every patient has access to world-class cancer care within days of diagnosis.
At our London centre, many of our consultants are renowned in their field, working at prestigious university-affiliated teaching hospitals. This means they have extensive experience and are familiar with the London healthcare networks.
Our clinical governance teams oversee the development of the best practice, innovative protocols and clinical evaluation as well as approval of all consultants to practise at our centres.